GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic pulmonary fibrosis...
Lire la suiteJohnson & Johnson has reported what it describes as unprecedented phase 3 results from the MajesTEC-3 study, positioning TECVAYLI...
Lire la suiteBen & Jerry’s is doubling down on indulgence as it unveils two new ice creams inspired by classic bakery...
Lire la suiteJohnson & Johnson has secured European Commission (EC) approval for nipocalimab, to be marketed as IMAAVY, as an add-on...
Lire la suiteEvotec SE has announced a key clinical milestone in its long-standing kidney disease partnership with Bayer AG, as Bayer...
Lire la suiteThe UK egg products sector has taken a significant step towards greater stability and resilience with the formation of...
Lire la suite